Drug Trial Radar · NCT06373146
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Last checked: Nov 20, 2026Latest source record: May 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
392
Actual
Start
Apr 24, 2024
Primary completion
Dec 15, 2025
Study completion Apr 2, 2026
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- Collaborators
- Regeneron Pharmaceuticals
- First posted
- Apr 18, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to determine if combining tirzepatide with mibavademab will result in more weight loss in adult participants than tirzepatide alone. The study will last about 74 weeks and may include up to 19 visits.
Conditions
- Obesity
Interventions
TirzepatideDrug
Administered SC
MibavademabDrug
Administered SC
Tirzepatide-PlaceboDrug
Administered SC
Mibavademab-PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change from Baseline in Body WeightTime frame: Baseline, Week 48
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Velocity Clinical Research, Gardena
Gardena, California
Irvine Clinical Research
Irvine, California
Velocity Clinical Research, Los Angeles
Los Angeles, California
Velocity Clinical Research, North Hollywood
North Hollywood, California
Velocity Clinical Research, Santa Ana
Santa Ana, California
Velocity Clinical Research, Panorama City
Van Nuys, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Solaris Clinical Research
Meridian, Idaho
Tandem Clinical Research
Marrero, Louisiana
Velocity Clinical Research - New Orleans
New Orleans, Louisiana
Hassman Research Institute Marlton Site
Marlton, New Jersey
Lillestol Research
Fargo, North Dakota
CTI Clinical Research Center
Cincinnati, Ohio
South Texas Clinical Research
Corpus Christi, Texas
Velocity Clinical Research, Dallas
Dallas, Texas
Juno Research
Houston, Texas
Northwest Clinical Research Center
Bellevue, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.